Treating type 2 diabetes mellitus with traditional chinese and indian medicinal herbs

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Zhijun ^a   Wang, Jeffrey ^a   Chan, Patrick ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; COPTIS RHIZOME EXTRACT; FOLIUM MORI EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GYMNEMA SYLVESTRE EXTRACT; GYMNEMIC ACID; INSULIN; LINAGLIPTIN; METFORMIN; MOMORDICA CHARANTIA EXTRACT; MULBERRY EXTRACT; NATEGLINIDE; PLACEBO; PRAMLINTIDE; ROSIGLITAZONE; SAXAGLIPTIN; SITAGLIPTIN; STEPHANIA TETRANDRA EXTRACT; TINOSPORA CORDIFOLIA EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; TROGLITAZONE; UNCLASSIFIED DRUG; VALSARTAN;

ALTERNATIVE MEDICINE; BARRINGTONIA RACEMOSA; BASIL; BERBERIS ARISTATA; CHINESE MEDICINE; CLINICAL TRIAL; DRUG COST; DRUG WITHDRAWAL; GYMNEMA SYLVESTRE; HERB; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDIAN MEDICINE; LIFESTYLE MODIFICATION; LIVER INJURY; LOQUAT; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATIENT EDUCATION; PRIORITY JOURNAL; PUERARIA LOBATA; REVIEW;

EID: 84878699348     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/343594     Document Type: Review

References (166)

1. Zimmet P., Alberti K. G. M. M., Shaw J., Global and societal implications of the diabetes epidemic. Nature 2001 414 6865 782 787 2-s2.0-0035856920 10.1038/414782a (Pubitemid 34000780)
2. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
3. World Health Organization, Diabetes: Key Facts 2011 Geneva, Switzerland World Health Organization
4. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
5. Centers for Disease Control and Prevention, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and preDiabetes in the United States, 2011 2011 Atlanta, Ga, USA U.S. Department of Health and Human Services, Centers for Disease Control and Prevention
6. Standards of medical care in diabetes-2012. Diabetes Care 2012 35 supplement 1 S11 S63
7. Inzucchi S. E., Bergenstal R. M., Buse J. B., Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012 55 6 1577 1596
8. Galuska D., Zierath J., Thorne A., Sonnenfeld T., Wallberg-Henriksson H., Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle. Diabete et Metabolisme 1991 17 1 159 163 2-s2.0-0025872553
9. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J. E., Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. New England Journal of Medicine 1995 333 9 550 554 2-s2.0-0029133235 10.1056/ NEJM199508313330903
10. Matthaei S., Greten H., Evidence that metformin ameliorates cellular insulin-resistance by potentiating insulin-induced translocation of glucose transporters to the plasma membrane. Diabete et Metabolisme 1991 17 1 150 158 2-s2.0-0025758256
11. Knowler W. C., Barrett-Connor E., Fowler S. E., Hamman R. F., Lachin J. M., Walker E. A., Nathan D. M., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 2002 346 6 393 403 2-s2.0-0037034257 10.1056/NEJMoa012512 (Pubitemid 34437694)
12. Hales C. N., Milner R. D., The role of sodium and potassium in insulin secretion from rabbit pancreas. Journal of Physiology 1968 194 3 725 743 2-s2.0-0014249974
13. Yki-Jarvinen H., Thiazolidinediones. The New England Journal of Medicine 2004 351 11 1106 1118
14. Nissen S. E., Wolski K., Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. New England Journal of Medicine 2007 356 24 2457 2471 2-s2.0-34250212715 (Pubitemid 46919772)
15. Drucker D. J., Nauck M. A., The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet 2006 368 9548 1696 1705 2-s2.0-33846006173 10.1016/S0140-6736(06)69705-5 (Pubitemid 46048557)
16. Gerich J., Raskin P., Jean-Louis L., Purkayastha D., Baron M. A., PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin. Diabetes Care 2005 28 9 2093 2099 2-s2.0-24144480574 10.2337/diacare.28.9.2093 (Pubitemid 41242450)
17. Van de Laar F. A., Lucassen P. L., Akkermans R. P., Van de Lisdonk E. H., De Grauw W. J., Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database of Systematic Reviews 2006 4 CD005061 2-s2.0-39049195349
18. Peters A., Incretin-based therapies: review of current clinical trial data. American Journal of Medicine 2010 123 supplement 3 S28 S37 2-s2.0-77449094873 10.1016/j.amjmed.2009.12.007
19. Hoogwerf B. J., Doshi K. B., Diab D., Pramlintide,the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk. Vascular Health and Risk Management 2008 4 2 355 362 2-s2.0-44049097336 (Pubitemid 351711964)
20. Samsom M., Szarka L. A., Camilleri M., Vella A., Zinsmeister A. R., Rizza R. A., Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. American Journal of Physiology 2000 278 6 G946 G951 2-s2.0-0033949323 (Pubitemid 30439174)
21. Nathan D. M., Davidson M. B., DeFronzo R. A., Heine R. J., Henry R. R., Pratley R., Zinman B., Kahn R., Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007 30 3 753 759 2-s2.0-33847645068 10.2337/dc07-9920 (Pubitemid 46354366)
22. Buchanan T. A., Xiang A. H., Peters R. K., Kjos S. L., Marroquin A., Goico J., Ochoa C., Tan S., Berkowitz K., Hodis H. N., Azen S. P., Preservation of pancreatic β -cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002 51 9 2796 2803 2-s2.0-0036724346 (Pubitemid 34970933)
23. Chiasson J. L., Josse R. G., Gomis R., Hanefeld M., Karasik A., Laakso M., Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet 2002 359 9323 2072 2077 2-s2.0-0037097039 10.1016/S0140-6736(02)08905-5 (Pubitemid 34680970)
24. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A. D., Vijay V., The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006 49 2 289 297 2-s2.0-31844452061 10.1007/s00125-005-0097-z (Pubitemid 43185397)
25. Ramachandran A., Snehalatha C., Mary S., Selvam S., Kumar C. K. S., Seeli A. C., Shetty A. S., Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia 2009 52 6 1019 1026 2-s2.0-67349125192 10.1007/s00125-009-1315-x
26. Gerstein H. C., Yusuf S., Bosch J., Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. The Lancet 2006 368 9541 1096 1105
27. Holman R. R., Haffner S. M., McMurray J. J., Effect of nateglinide on the incidence of diabetes and cardiovascular events. The New England Journal of Medicine 2010 362 16 1463 1476
28. Zinman B., Harris S. B., Neuman J., Gerstein H. C., Retnakaran R. R., Raboud J., Qi Y., Hanley A. J. G., Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. The Lancet 2010 376 9735 103 111 2-s2.0-77955013179 10.1016/S0140-6736(10)60746-5
29. Torgerson J. S., Hauptman J., Boldrin M. N., Sjöström L., XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004 27 1 155 161 2-s2.0-1042303480 10.2337/diacare.27.1.155 (Pubitemid 38196725)
30. AHFS Drug Information, Authority of the Board of the American Socitey of Health-System Pharamcists 2012 Bethesda, Md, USA American Hospital Formulary Service
31. Li W. L., Zheng H. C., Bukuru J., De Kimpe N., Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004 92 1 1 21 2-s2.0-1942424088 10.1016/j.jep.2003.12.031 (Pubitemid 38510258)
32. Prabhakar P. K., Doble M., Mechanism of action of natural products used in the treatment of diabetes mellitus. Chinese Journal of Integrative Medicine 2011 17 8 563 574
33. Yang L. X., Liu T. H., Huang Z. T., Li J. E., Wu L. L., Research progress on the mechanism of single-chinese medicinal herbs in treating diabetes mellitus. Chinese Journal of Integrative Medicine 2011 17 3 235 240 2-s2.0-79952553032 10.1007/s11655-010-0674-6
34. Jia W., Gaoz W., Tang L., Antidiabetic herbal drugs officially approved in China. Phytotherapy Research 2003 17 10 1127 1134 2-s2.0-0346095665 10.1002/ptr.1398 (Pubitemid 38057166)
35. Ceylan-Isik A. F., Fliethman R. M., Wold L. E., Ren J., Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus. Current Diabetes Reviews 2008 4 4 320 328 2-s2.0-59849117369
36. Bhat M., Zinjarde S. S., Bhargava S. Y., Kumar A. R., Joshi B. N., Antidiabetic Indian plants: a good source of potent amylase inhibitors. Evidence-Based Complementary and Alternative Medicine 2011 2011 810207 10.1093/ecam/nen040
37. Grover J. K., Yadav S., Vats V., Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology 2002 81 1 81 100 2-s2.0-0036000246 10.1016/S0378-8741(02)00059-4 (Pubitemid 34518472)
38. Zhu X. M., Xie P., Di Y. T., Peng S. L., Ding L. S., Wang M. K., Two new triterpenoid saponins from Gymnema sylvestre. Journal of Integrative Plant Biology 2008 50 5 589 592 2-s2.0-43049093771 10.1111/j.1744-7909.2008.00661.x (Pubitemid 351627121)
39. Ahmed A. B. A., Rao A. S., Rao M. V., In vitro callus and in vivo leaf extract of Gymnema sylvestre stimulate β -cells regeneration and anti-diabetic activity in Wistar rats. Phytomedicine 2010 17 13 1033 1039 2-s2.0-77957821707 10.1016/j.phymed.2010.03.019
40. Daisy P., Eliza J., Mohamed Farook K. A. M., A novel dihydroxy gymnemic triacetate isolated from Gymnema sylvestre possessing normoglycemic and hypolipidemic activity on STZ-induced diabetic rats. Journal of Ethnopharmacology 2009 126 2 339 344 2-s2.0-70350346877 10.1016/j.jep.2009.08. 018
41. Nahas R., Moher M., Complementary and alternative medicine for the treatment of type 2 diabetes. Canadian Family Physician 2009 55 6 591 596 2-s2.0-67249114413
42. Kumar S. N., Mani U. V., Mani I., An open label study on the supplementation of gymnema sylvestre in type 2 diabetics. Journal of Dietary Supplements 2010 7 supplement 3 273 282 2-s2.0-77955586354 10.3109/19390211. 2010.505901
43. Leung L., Birtwhistle R., Kotecha J., Hannah S., Cuthbertson S., Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. British Journal of Nutrition 2009 102 12 1703 1708 2-s2.0-74949111350 10.1017/S0007114509992054
44. Welihinda J., Karunanayake E. H., Sheriff M. H. R., Jayasinghe K. S. A., Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. Journal of Ethnopharmacology 1986 17 3 277 282 2-s2.0-0023003760 (Pubitemid 17209188)
45. Ahmad N., Hassan M. R., Halder H., Bennoor K. S., Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Medical Research Council bulletin 1999 25 1 11 13 2-s2.0-0033107711
46. Tongia A., Tongia S. K., Dave M., Phytochemical determination and extraction of momordica charantia fruit and its hypoglycemic potentiation of oral hypoglycemic drugs in diabetes mellitus (NIDDM). Indian Journal of Physiology and Pharmacology 2004 48 2 241 244 2-s2.0-1842418813 (Pubitemid 38436928)
47. Hafizur R. M., Kabir N., Chishti S., Modulation of pancreatic β -cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp. Natural Product Research 2011 25 4 353 367 2-s2.0-79951740993 10.1080/14786411003766904
48. Kim H., Jang M. H., Shin M. C., Chang H. K., Lee T. H., Lim B. V., Jung C. Y., Lee C. Y., Kim E. H., Kim C. J., Folium mori increases cell proliferation and neuropeptide Y expression in dentate gyrus of streptozotocin-induced diabetic rats. Biological and Pharmaceutical Bulletin 2003 26 4 434 437 2-s2.0-10844294219 (Pubitemid 39663586)
49. Tanabe K., Nakamura S., Omagari K., Oku T., Repeated ingestion of the leaf extract from Morus alba reduces insulin resistance in KK-Ay mice. Nutrition Research 2011 31 11 848 854
50. Park S. C., Yoo H. S., Park C., Cho C. K., Kim G. Y., Kim W. J., Lee Y. W., Choi Y. H., Induction of apoptosis in human lung carcinoma cells by the water extract of Panax notoginseng is associated with the activation of caspase-3 through downregulation of Akt. International Journal of Oncology 2009 35 1 121 127 2-s2.0-67649415914 10.3892/ijo-00000320
51. Kimura T., Nakagawa K., Kubota H., Kojima Y., Goto Y., Yamagishi K., Oita S., Oikawa S., Miyazawa T., Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. Journal of Agricultural and Food Chemistry 2007 55 14 5869 5874 2-s2.0-34447631185 10.1021/jf062680g (Pubitemid 47092969)
52. Naowaboot J., Chung C. H., Pannangpetch P., Mulberry leaf extract increases adiponectin in murine 3T3-L1 adipocytes. Nutrition Research 2012 32 1 39 44
53. Naowaboot J., Pannangpetch P., Kukongviriyapan V., Mulberry leaf extract stimulates glucose uptake and GLUT4 translocation in rat adipocytes. The American Journal of Chinese Medicine 2012 40 1 163 175
54. Oku T., Yamada M., Nakamura M., Sadamori N., Nakamura S., Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. British Journal of Nutrition 2006 95 5 933 938 2-s2.0-33744460723 10.1079/BJN20061746 (Pubitemid 43805380)
55. Bawadi H. A., Maghaydah S. N., Tayyem R. F., Tayyem R. F., The postprandial hypoglycemic activity of fenugreek seed and seeds' extract in type 2 diabetics: a pilot study. Pharmacognosy Magazine 2009 4 18 134 138 2-s2.0-74049085422
56. Pang X., Kang L., Yu H., Rapid isolation of new furostanol saponins from fenugreek seeds based on ultra-performance liquid chromatography coupled with a hybrid quadrupole time-of-flight tandem mass spectrometry. Journal of Separation Science 2012 35 12 1538 1550
57. Mandegary A., Pournamdari M., Sharififar F., Alkaloid and flavonoid rich fractions of fenugreek seeds (Trigonella foenum-graecum L.) with antinociceptive and anti-inflammatory effects. Food and Chemical Toxicology 2012 50 7 2503 2507
58. Mishkinsky J. S., Goldschmied A., Joseph B., Hypoglycaemic effect of Trigonella foenum graecum and Lupinus termis (Leguminosae) seeds and their major alkaloids in alloxan diabetic and normal rats. Archives Internationales de Pharmacodynamie et de Therapie 1974 210 1 27 37 2-s2.0-0016264635
59. Broca C., Gross R., Petit P., Sauvaire Y., Manteghetti M., Tournier M., Masiello P., Gomis R., Ribes G., 4-hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. American Journal of Physiology 1999 277 4 E617 E623 2-s2.0-0032760014 (Pubitemid 29522613)
60. Vijayakumar M. V., Singh S., Chhipa R. R., Bhat M. K., The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway. British Journal of Pharmacology 2005 146 1 41 48 2-s2.0-30644477939 10.1038/sj.bjp.0706312 (Pubitemid 43086093)
61. Broca C., Breil V., Cruciani-Guglielmacci C., Manteghetti M., Rouault C., Derouet M., Rizkalla S., Pau B., Petit P., Ribes G., Ktorza A., Gross R., Reach G., Taouis M., Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat. American Journal of Physiology 2004 287 3 E463 E471 2-s2.0-4143074679 10.1152/ajpendo.00163.2003 (Pubitemid 39095880)
62. Devi B. A., Kamalakkannan N., Prince P. S. M., Supplementation of fenugreek leaves to diabetic rats. Effect on carbohydrate metabolic enzymes in diabetic liver and kidney. Phytotherapy Research 2003 17 10 1231 1233 2-s2.0-0347987009 10.1002/ptr.1357 (Pubitemid 38057187)
63. Vijayakumar M. V., Bhat M. K., Hypoglycemic effect of a novel dialysed fenugreek seeds extract is sustainable and is mediated, in part, by the activation of hepatic enzymes. Phytotherapy Research 2008 22 4 500 505 2-s2.0-42949108213 10.1002/ptr.2351 (Pubitemid 351613415)
64. Madar Z., Abel R., Samish S., Arad J., Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. European Journal of Clinical Nutrition 1988 42 1 51 54 2-s2.0-0023872236
65. Sharma R. D., Raghuram T. C., Rao N. S., Effect of fenugreek seeds on blood glucose and serum lipids in Type I diabetes. European Journal of Clinical Nutrition 1990 44 4 301 306 2-s2.0-0025284666 (Pubitemid 20177218)
66. Mathern J. R., Raatz S. K., Thomas W., Slavin J. L., Effect of fenugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects. Phytotherapy Research 2009 23 11 1543 1548 2-s2.0-70350447051 10.1002/ptr.2795
67. Suksomboon N., Poolsup N., Boonkaew S., Suthisisang C. C., Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. Journal of Ethnopharmacology 2011 137 3 1328 1333
68. Wang Z.-J., Wo S.-K., Wang L., Lau C. B. S., Lee V. H. L., Chow M. S. S., Zuo Z., Simultaneous quantification of active components in the herbs and products of Si-Wu-Tang by high performance liquid chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2009 50 2 232 244 2-s2.0-67349223507 10.1016/j.jpba.2009.04.001
69. Park S. M., Hong S. M., Sung S. R., Lee J. E., Kwon D. Y., Extracts of rehmanniae radix, ginseng radix and Scutellariae radix improve glucose-stimulated insulin secretion and beta-cell proliferation through IRS2 induction. Genes and Nutrition 2008 2 4 347 351 2-s2.0-41349098358 10.1007/s12263-007-0065-y (Pubitemid 351447710)
70. Lau K.-M., Lai K.-K., Liu C.-L., Synergistic interaction between Astragali Radix and Rehmanniae Radix in a Chinese herbal formula to promote diabetic wound healing. Journal of Ethnopharmacology 2012 141 1 250 256
71. Kiho T., Watanabe T., Nagai K., Ukai S., Hypoglycemic activity of polysaccharide fraction from rhizome of Rehmannia glutinosa Libosch. f. hueichingensis Hsiao and the effect on carbohydrate metabolism in normal mouse liver. Yakugaku Zasshi 1992 112 6 393 400 2-s2.0-0026689879
72. Ma W., Nomura M., Takahashi-Nishioka T., Kobayashi S., Combined effects of fangchinoline from Stephania tetrandra Radix and formononetin and calycosin from Astragalus membranaceus radix on hyperglycemia and hypoinsulinemia in streptozotocin-diabetic mice. Biological and Pharmaceutical Bulletin 2007 30 11 2079 2083 2-s2.0-36049007935 10.1248/bpb.30.2079 (Pubitemid 350097043)
73. Wong T. M., Wu S., Yu X. C., Li H. Y., Cardiovascular actions of radix stephaniae tetrandrae: a comprison with its main component, tetrandrine. Acta Pharmacologica Sinica 2000 21 12 1083 1088 2-s2.0-0034528591 (Pubitemid 32012714)
74. Tsutsumi T., Kobayashi S., Liu Y. Y., Kontani H., Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice. Biological and Pharmaceutical Bulletin 2003 26 3 313 317 2-s2.0-0037703416 (Pubitemid 39663616)
75. Lin S. L., Zhao L. H., Wang Y. M., Dong S. S., An D. K., Determination of berberine in Angong Niuhuang Wan by HPLC. Acta Pharmaceutica Sinica 1989 24 1 48 52 2-s2.0-0024393150 (Pubitemid 19176300)
76. Huang Z. J., Zeng Y., Lan P., Sun P. H., Chen W. M., Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine. Mini-Reviews in Medicinal Chemistry 2011 11 13 1122 1129 10.2174/138955711797655362
77. Xia X., Yan J., Shen Y., Tang K., Yin J., Zhang Y., Yang D., Liang H., Ye J., Weng J., Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS ONE 2011 6 2 2-s2.0-79751496044 10.1371/journal.pone.0016556 e16556
78. Jung H. A., Yoon N. Y., Bae H. J., Min B. S., Choi J. S., Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase. Archives of Pharmacal Research 2008 31 11 1405 1412 2-s2.0-56749132290 10.1007/s12272-001-2124-z
79. Song J.-Z., Yiu H. H. W., Qiao C. F., Han Q. B., Xu H. X., Chemical comparison and classification of Radix Astragali by determination of isoflavonoids and astragalosides. Journal of Pharmaceutical and Biomedical Analysis 2008 47 2 399 406 2-s2.0-42749097819 10.1016/j.jpba.2007.12.036
80. Lu Z. M., Yu Y. R., Tang H., Zhang X. X., The protective effects of Radix Astragali and Rhizoma Ligustici Chuanxiong on endothelial dysfunction in type 2 diabetic patients with microalbuminuria. Journal of Sichuan University 2005 36 4 529 532 2-s2.0-23244449231 (Pubitemid 41097948)
81. Ito H., Kobayashi E., Li S. H., Hatano T., Sugita D., Kubo N., Shimura S., Itoh Y., Tokuda H., Nishino H., Yoshida T., Antitumor activity of compounds isolated from leaves of Eriobotrya japonica. Journal of Agricultural and Food Chemistry 2002 50 8 2400 2403 2-s2.0-0037051517 10.1021/jf011083l (Pubitemid 34275316)
82. Lee E. H., Song D. G., Lee J. Y., Pan C. H., Um B. H., Jung S. H., Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biological and Pharmaceutical Bulletin 2008 31 8 1626 1630 2-s2.0-48849111676 10.1248/bpb.31.1626
83. Li E.-N., Luo J.-G., Kong L.-Y., Qualitative and quantitative determination of seven triterpene acids in Eriobotrya japonica Lindl. by high-performance liquid chromatography with photodiode array detection and mass spectrometry. Phytochemical Analysis 2009 20 4 338 343 2-s2.0-67651053233 10.1002/pca.1134
84. Qa'dan F., Verspohl E. J., Nahrstedt A., Petereit F., Matalka K. Z., Cinchonain Ib isolated from Eriobotrya japonica induces insulin secretion in vitro and in vivo. Journal of Ethnopharmacology 2009 124 2 224 227 2-s2.0-67449132103 10.1016/j.jep.2009.04.023
85. Li W.-L., Wu J.-L., Ren B.-R., Chen J., Lu C. G., Pharmacological studies on anti-hyperglycemic effect of folium eriobotryae. American Journal of Chinese Medicine 2007 35 4 705 711 2-s2.0-34548181077 10.1142/S0192415X07005193 (Pubitemid 47307708)
86. Shih C.-C., Lin C.-H., Wu J.-B., Eriobotrya japonica improves hyperlipidemia and reverses insulin resistance in high-fat-fed mice. Phytotherapy Research 2010 24 12 1769 1780 2-s2.0-78649637009 10.1002/ptr.3143
87. Tamaya K., Matsui T., Toshima A., Noguchi M., Ju Q., Miyata Y., Tanaka T., Tanaka K., Suppression of blood glucose level by a new fermented tea obtained by tea-rolling processing of loquat (Eriobotrya japonica) and green tea leaves in disaccharide-loaded Sprague-Dawley rats. Journal of the Science of Food and Agriculture 2010 90 5 779 783 2-s2.0-77649313250 10.1002/jsfa.3883
88. ginkgo. Encyclopaedia Britannica Encyclopaedia Britannica Online 2012 London, UK Encyclopaedia Britannica
89. Jacobs B. P., Browner W. S., Ginkgo biloba: a living fossil. American Journal of Medicine 2000 108 4 341 342 2-s2.0-0033974910 10.1016/S0002-9343(00) 00290-4 (Pubitemid 30110466)
90. Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M., Kessler R. C., Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Journal of the American Medical Association 1998 280 18 1569 1575 2-s2.0-0032508952 (Pubitemid 28520643)
91. Cohen A. J., Bartlik B., Ginkgbiloba for antidepressant-induced sexual dysfunction. Journal of Sex and Marital Therapy 1998 24 2 139 143 2-s2.0-0031595609 (Pubitemid 28189166)
92. Pittler M. H., Ernst E., Ginkgo Biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. American Journal of Medicine 2000 108 4 276 281 2-s2.0-0033954629 10.1016/S0002-9343(99) 00454-4 (Pubitemid 30110455)
93. D'Andrea G., Bussone G., Allais G., Aguggia M., D'Onofrio F., Maggio M., Moschiano F., Saracco M. G., Terzi M. G., Petretta V., Benedetto C., Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurological Sciences 2009 30 supplement 1 S121 S124 2-s2.0-65549086987 10.1007/s10072-009-0074-2
94. Holgers K. M., Axelsson A., Pringle I., Ginkgo biloba extract for the treatment of tinnitus. Audiology 1994 33 2 85 92 2-s2.0-0028052978 (Pubitemid 24057146)
95. Sierpina V. S., Wollschlaeger B., Blumenthal M., Ginkgo biloba. American Family Physician 2003 68 5 923 926 2-s2.0-0041834580 (Pubitemid 37093220)
96. Ihl R., Tribanek M., Bachinskaya N., Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial. Journal of the Neurological Sciences 2010 299 1-2 184 187 2-s2.0-78649498958 10.1016/j.jns.2010.08.033
97. Oken B. S., Storzbach D. M., Kaye J. A., The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Archives of Neurology 1998 55 11 1409 1415 2-s2.0-0031788259 (Pubitemid 28525500)
98. Le Bars P. L., Katz M. M., Berman N., Itil T. M., Freedman A. M., Schatzberg A. F., A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. Journal of the American Medical Association 1997 278 16 1327 1332 2-s2.0-0030759072 (Pubitemid 27449692)
99. Rogers S. L., Farlow M. R., Doody R. S., Mohs R., Friedhoff L. T., A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998 50 1 136 145 2-s2.0-0031883716
100. Napryeyenko O., Sonnik G., Tartakovsky I., Efficacy and tolerability of Ginkgo biloba extract EGb 761® by type of dementia: analyses of a randomised controlled trial. Journal of the Neurological Sciences 2009 283 1-2 224 229 2-s2.0-67650565600 10.1016/j.jns.2009.02.353
101. Rapin J. R., Yoa R. G., Bouvier C., Drieu K., Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on liver and muscle glycogen contents in the non-insulin-dependent diabetic rat. Drug Development Research 1998 40 1 68 74 (Pubitemid 27208533)
102. Lim S., Yoon J. W., Kang S. M., Choi S. H., Cho B. J., Kim M., Park H. S., Cho H. J., Shin H., Kim Y. B., Kim H. S., Jang H. C., Park K. S., Egb761, a ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS ONE 2011 6 6 2-s2.0-79957954733 10.1371/journal.pone.0020301 e20301
103. da Silva Pinto M., Kwon Y. I., Apostolidis E., Lajolo F. M., Genovese M. I., Shetty K., Potential of Ginkgo biloba L. leaves in the management of hyperglycemia and hypertension using in vitro models. Bioresource Technology 2009 100 24 6599 6609 2-s2.0-69249220318 10.1016/j.biortech.2009.07.021
104. Kudolo G. B., The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic β -cell function in response to glucose loading in normal glucose tolerant individuals. Journal of Clinical Pharmacology 2000 40 6 647 654 2-s2.0-0033672787
105. Kudolo G. B., Wang W., Elrod R., Barrientos J., Haase A., Blodgett J., Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects-a randomized double-blind placebo-controlled crossover study. Clinical Nutrition 2006 25 1 123 134 2-s2.0-33144470037 10.1016/j.clnu.2005.10.001 (Pubitemid 43263536)
106. Kudolo G. B., Wang W., Javors M., Blodgett J., The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects-A double blind placebo-controlled, crossover study. Clinical Nutrition 2006 25 4 606 616 2-s2.0-33746092899 10.1016/j.clnu.2005.12.012 (Pubitemid 44070589)
107. Li X. S., Zheng W. Y., Lou S. X., Lu X. W., Ye S. H., Effect of ginkgo leaf extract on vascular endothelial function in patients with early stage diabetic nephropathy. Chinese Journal of Integrative Medicine 2009 15 1 26 29 2-s2.0-60849102780 10.1007/s11655-009-0026-8
108. Qi L.-W., Wang C.-Z., Yuan C.-S., Isolation and analysis of ginseng: advances and challenges. Natural Product Reports 2011 28 3 467 495 2-s2.0-79952012614 10.1039/c0np00057d
109. Jia L., Zhao Y., Liang X. J., Current evaluation of the millennium phytomedicine-ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional chinese medicine. Current Medicinal Chemistry 2009 16 22 2924 2942 2-s2.0-70349408655 10.2174/ 092986709788803204
110. Kim E. K., Song M. Y., Hwang T. O., Kim H. J., Moon W. S., Ryu D. G., So H. S., Park R., Park J. W., Kwon K. B., Park B. H., Radix clematidis extract protects against cytokine-and streptozotocin-induced β -cell damage by suppressing the NF- B pathway. International Journal of Molecular Medicine 2008 22 3 349 356 2-s2.0-53049098766 10.3892/ijmm-00000029
111. Sotaniemi E. A., Haapakoski E., Rautio A., Ginseng therapy in non-insulin-dependent diabetic patients. Effects of psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight. Diabetes Care 1995 18 10 1373 1375 2-s2.0-0029097005
112. Vuksan V., Sievenpiper J. L., Koo V. Y. Y., Francis T., Beljan-Zdravkovic U., Xu Z., Vidgen E., American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Archives of Internal Medicine 2000 160 7 1009 1013 2-s2.0-0034630423 (Pubitemid 30191931)
113. Vuksan V., Stavro M. P., Sievenpiper J. L., Beljan-Zdravkovic U., Leiter L. A., Josse R. G., Xu Z., Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 2000 23 9 1221 1226 2-s2.0-0033858725
114. Vuksan V., Sievenpiper J. L., Wong J., Xu Z., Beljan-Zdravkovic U., Arnason J. T., Assinewe V., Stavro M. P., Jenkins A. L., Leiter L. A., Francis T., American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. American Journal of Clinical Nutrition 2001 73 4 753 758 2-s2.0-0035081321 (Pubitemid 32241810)
115. Vuksan V., Sung M. K., Sievenpiper J. L., Stavro P. M., Jenkins A. L., Di Buono M., Lee K. S., Leiter L. A., Nam K. Y., Arnason J. T., Choi M., Naeem A., Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism and Cardiovascular Diseases 2008 18 1 46 56 2-s2.0-37349037807 10.1016/j.numecd. 2006.04.003 (Pubitemid 350297892)
116. Zhang J. Q., Progress of diabetes research in traditional Chinese medicine in recent years. Journal of Chinese Integrative Medicine 2007 5 4 373 377 2-s2.0-34547112857
117. Yoon M., Lee H., Jeong S., Kim J. J., Nicol C. J., Nam K. W., Kim M., Cho B. G., Oh G. T., Peroxisome proliferator-activated receptor is involved in the regulation of lipid metabolism by ginseng. British Journal of Pharmacology 2003 138 7 1295 1302 2-s2.0-0038077329 10.1038/sj.bjp.0705169 (Pubitemid 36543127)
118. Jung I. H., Lee J. H., Hyun Y. J., Kim D. H., Metabolism of ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing beta-D-glucosidase from Bifidobacterium longum H-1. Biological and Pharmaceutical Bulletin 2012 35 4 573 581 10.1248/bpb.35.573
119. Shang W., Yang Y., Jiang B., Jin H., Zhou L., Liu S., Chen M., Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPAR γ 2 and C/EBP α gene expression. Life Sciences 2007 80 7 618 625 2-s2.0-33846064201 10.1016/j.lfs.2006.10.021 (Pubitemid 46074052)
120. Kong H. L., Wang J. P., Li Z. Q., Zhao S. M., Dong J., Zhang W. W., Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo. Acta Pharmacologica Sinica 2009 30 4 396 403 2-s2.0-65249131690 10.1038/aps.2009.2
121. Kwon D. Y., Kim D. S., Yang H. J., Park S., The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR- γ pathways in in vitro and in vivo studies. Journal of Ethnopharmacology 2011 135 2 455 462 2-s2.0-79955682914 10.1016/j.jep.2011.03.037
122. Lukacova V., Woltosz W. S., Bolger M. B., Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data. AAPS Journal 2009 11 2 323 334 2-s2.0-68249162210 10.1208/s12248-009-9107-2
123. Gu B. H., Van Minh N., Lee S. H., Lim S. W., Lee Y. M., Lee K. S., Kim D. K., Deoxyschisandrin inhibits H2O2-induced apoptotic cell death in intestinal epithelial cells through nuclear factor- B. International Journal of Molecular Medicine 2010 26 3 401 406 2-s2.0-77956692449 10.3892/ijmm-00000479
124. Wong K. H., Li G. Q., Li K. M., Razmovski-Naumovski V., Chan K., Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. Journal of Ethnopharmacology 2011 134 3 584 607 2-s2.0-79954422522 10.1016/j.jep.2011.02.001
125. Luo Q., Hao J. D., Yang Y., Yi H., Herbalogical textual research on 'Gegen'. Zhongguo Zhongyao Zazhi 2007 32 12 1141 1144 2-s2.0-34547638991
126. Hsu F. L., Liu I. M., Kuo D. H., Chen W. C., Su H. C., Cheng J. T., Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. Journal of Natural Products 2003 66 6 788 792 2-s2.0-0038204299
127. Song X. P., Chen P. P., Chai X. S., Effects of puerarin on blood pressure
128. Xu M.-E., Xiao S.-Z., Sun Y.-H., Zheng X. X., Ou Y., Guan C., The study of anti-metabolic syndrome effect of puerarin in vitro. Life Sciences 2005 77 25 3183 3196 2-s2.0-26444471844 10.1016/j.lfs.2005.03.036 (Pubitemid 41433319)
129. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M., 15-deoxy-Δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ Cell 1995 83 5 803 812 2-s2.0-0028972025 (Pubitemid 3006324)
130. Tong X. L., Zhao L. H., Lian F. M., Zhou Q., Xia L., Zhang J. C., Chen X. Y., Ji H. Y., Clinical observations on the dose-effect relationship of Gegen Qin Lian Decoction on 54 out-patients with type 2 diabetes. Journal of Traditional Chinese Medicine 2011 31 1 56 59 2-s2.0-79956141290
131. He K., Li X., Chen X., Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice. Journal of Ethnopharmacology 2011 137 3 1135 1142 10.1016/j.jep.2011.07.033
132. Fu-Liang X., Xiao-Hui S., Lu G., Xiang-Liang Y., Hui-Bi X., Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. European Journal of Pharmacology 2006 529 1-3 1 7 2-s2.0-29344444326 10.1016/j.ejphar. 2005.10.024 (Pubitemid 43005278)
133. Yeo J., Kang Y. M., Cho S. I., Jung M. H., Effects of a multi-herbal extract on type 2 diabetes. Chinese Medicine 2011 6 10 2-s2.0-79952197919 10.1186/1749-8546-6-10
134. Chen C.-C., Hsu C.-Y., Chen C.-Y., Liu H.-K., Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death. Journal of Ethnopharmacology 2008 117 3 483 490 2-s2.0-42949179698 10.1016/j.jep.2008.02.032
135. Cao G., Zhang C., Zhang Y., Cong X., Cai H., Cai B., Screening and identification of potential active components in crude Fructus Corni using solid-phase extraction and LC-LTQ-linear ion trap mass spectrometry. Pharmaceutical Biology 2012 50 3 278 283 10.3109/13880209.2011.599036
136. Qian D. S., Zhu Y. F., Zhu Q., Effect of alcohol extract of cornus officinalis sieb. et zucc on GLUT4 expression in skeletal muscle in type 2 (non-insulin-dependent) diabetic mellitus rats. Zhongguo Zhongyao Zazhi 2001 26 12 861 862 2-s2.0-0141974754 (Pubitemid 33735718)
137. Zhang W., Hong D., Zhou Y., Zhang Y., Shen Q., Li J. Y., Hu L. H., Li J., Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochimica et Biophysica Acta 2006 1760 10 1505 1512 2-s2.0-33748882713 10.1016/j.bbagen.2006.05.009 (Pubitemid 44428024)
138. Patil K. R., Patil C. R., Jadhav R. B., Mahajan V. K., Patil P. R., Gaikwad P. S., Anti-arthritic activity of bartogenic acid isolated from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evidence-based Complementary and Alternative Medicine 2011 2011 2-s2.0-79953274914 10.1093/ecam/nep148 785245
139. Gowri P. M., Radhakrishnan S. V., Basha S. J., Sarma A. V. S., Madhusudana Rao J., Oleanane-type isomeric triterpenoids from Barringtonia racemosa. Journal of Natural Products 2009 72 4 791 795 2-s2.0-65649153805 10.1021/np8007396
140. Gowri P. M., Tiwari A. K., Ali A. Z., Rao J. M., Inhibition of α -glucosidase and amylase by bartogenic acid isolated from Barringtonia racemosa Roxb. seeds. Phytotherapy Research 2007 21 8 796 799 2-s2.0-34547650832 10.1002/ptr.2176 (Pubitemid 47217783)
141. Oliveira A. C. P., Endringer D. C., Amorim L. A. S., Brandão M. D. G. L., Coelho M. M., Effect of the extracts and fractions of Baccharis trimera and Syzygium cumini on glycaemia of diabetic and non-diabetic mice. Journal of Ethnopharmacology 2005 102 3 465 469 2-s2.0-27644457200 10.1016/j.jep.2005.06. 025 (Pubitemid 41571856)
142. Prince P. S. M., Kamalakkannan N., Menon V. P., Antidiabetic and antihyperlipidaemic effect of alcoholic Syzigium cumini seeds in alloxan induced diabetic albino rats. Journal of Ethnopharmacology 2004 91 2-3 209 213 2-s2.0-2342432418 10.1016/j.jep.2003.11.001 (Pubitemid 38561115)
143. Prince P. S. M., Menon V. P., Pari L., Hypoglycaemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. Journal of Ethnopharmacology 1998 61 1 1 7 2-s2.0-0032077187 10.1016/S0378-8741(98)00002-6 (Pubitemid 28276718)
144. Shinde J., Taldone T., Barletta M., Kunaparaju N., Hu B., Kumar S., Placido J., Zito S. W., Alpha-Glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats. Carbohydrate Research 2008 343 7 1278 1281 2-s2.0-41949139322 10.1016/j.carres.2008.03.003
145. Grover J. K., Vats V., Rathi S. S., Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. Journal of Ethnopharmacology 2000 73 3 461 470 2-s2.0-0033712738 10.1016/S0378-8741(00) 00319-6
146. Achrekar S., Kaklij G. S., Pote M. S., Kelkar S. M., Hypoglycemic activity of Eugenia jambolana and Ficus bengalensis: mechanism of action. In Vivo 1991 5 2 143 147 2-s2.0-0025843574
147. Teixeira C. C., Fuchs F. D., Weinert L. S., Esteves J., The efficacy of folk medicines in the management of type 2 diabetes mellitus: results of a randomized controlled trial of Syzygium cumini (L.) Skeels. Journal of Clinical Pharmacy and Therapeutics 2006 31 1 1 5 2-s2.0-33645113185 10.1111/j.1365-2710. 2006.00700.x
148. Teixeira C. C., Rava C. A., Mallman Da Silva P., Melchior R., Argenta R., Anselmi F., Almeida C. R. C., Fuchs F. D., Absence of antihyperglycemic effect of jambolan in experimental and clinical models. Journal of Ethnopharmacology 2000 71 1-2 343 347 2-s2.0-0033920680 10.1016/S0378-8741(00)00185-9 (Pubitemid 30440689)
149. Sengupta S., Mukherjee A., Ray L., Sengupta S., Tinospora cordifolia, a novel source of extracellular disaccharidases, useful for human disaccharidase deficiency therapy. Phytotherapy Research. In press
150. Grover J. K., Yadav S., Vats V., Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology 2002 81 1 81 100 2-s2.0-0036000246 10.1016/S0378-8741(02)00059-4 (Pubitemid 34518472)
151. Nadig P. D., Revankar R. R., Dethe S. M., Narayanswamy S. B., Aliyar M. A., Effect of Tinospora cordifolia on experimental diabetic neuropathy. Indian Journal of Pharmacology 2012 44 5 580 583 10.4103/0253-7613.100380
152. Patel M. B., Mishra S., Hypoglycemic activity of alkaloidal fraction of Tinospora cordifolia. Phytomedicine 2011 18 12 1045 1052 10.1016/j.phymed.2011. 05.006
153. Agrawal S. S., Naqvi S., Gupta S. K., Srivastava S., Prevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanisms. Food and Chemical Toxicology 2012 50 9 3126 3132 10.1016/j.fct.2012.05.057
154. Sangeetha M. K., Balaji Raghavendran H. R., Gayathri V., Vasanthi H. R., Tinospora cordifolia attenuates oxidative stress and distorted carbohydrate metabolism in experimentally induced type 2 diabetes in rats. Journal of Natural Medicines 2011 65 3-4 544 550 2-s2.0-79960463887 10.1007/s11418-011-0538-6
155. Chougale A. D., Ghadyale V. A., Panaskar S. N., Arvindekar A. U., Alpha glucosidase inhibition by stem extract of Tinospora cordifolia. Journal of Enzyme Inhibition and Medicinal Chemistry 2009 24 4 998 1001 2-s2.0-76249099854
156. Berić T., Nikolić B., Stanojević J., Vuković-Gačić B., Knežević- Vukčević J., Protective effect of basil (Ocimum basilicum L.) against oxidative DNA damage and mutagenesis. Food and Chemical Toxicology 2008 46 2 724 732 2-s2.0-37449033286 10.1016/j.fct.2007.09.102
157. Bora K. S., Arora S., Shri R., Role of Ocimum basilicum L. in prevention of ischemia and reperfusion-induced cerebral damage, and motor dysfunctions in mice brain. Journal of Ethnopharmacology 2011 137 3 1360 1365 10.1016/j.jep.2011.07.066
158. Chiang L.-C., Ng L.-T., Cheng P.-W., Chiang W., Lin C.-C., Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clinical and Experimental Pharmacology and Physiology 2005 32 10 811 816 2-s2.0-33644677359 10.1111/j.1440-1681.2005.04270.x (Pubitemid 43906523)
159. Harnafi H., Aziz M., Amrani S., Sweet basil (Ocimum basilicum L.) improves lipid metabolism in hypercholesterolemic rats. e-SPEN 2009 4 4 e181 e186 2-s2.0-72049085774 10.1016/j.eclnm.2009.05.011
160. Bravo E., Amrani S., Aziz M., Harnafi H., Napolitano M., Ocimum basilicum ethanolic extract decreases cholesterol synthesis and lipid accumulation in human macrophages. Fitoterapia 2008 79 7-8 515 523 2-s2.0-55049115381 10.1016/j.fitote.2008.05.002
161. El-Beshbishy H., Bahashwan S., Hypoglycemic effect of basil (Ocimum basilicum) aqueous extract is mediated through inhibition of alpha-glucosidase and alpha-amylase activities: an in vitro study. Toxicology and Industrial Health 2012 28 1 42 50 10.1177/0748233711403193
162. Agrawal P., Rai V., Singh R. B., Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. International Journal of Clinical Pharmacology and Therapeutics 1996 34 9 406 409 2-s2.0-0029835128 (Pubitemid 26305816)
163. Gilani A. H., Janbaz K. H., Aziz N., Herzig M. J. U., Kazmi M. M., Choudhary M. I., Herzig J. W., Possible mechanism of selective inotropic activity of the n-butanolic fraction from Berberis aristata fruit. General Pharmacology 1999 33 5 407 414 2-s2.0-0032753185 10.1016/S0306-3623(99)00035-X (Pubitemid 29507460)
164. Potdar D., Hirwani R. R., Dhulap S., Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia 2012 83 5 817 830 10.1016/j.fitote.2012.04.012
165. Singh J., Kakkar P., Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. Journal of Ethnopharmacology 2009 123 1 22 26 2-s2.0-64249131013 10.1016/j.jep.2009.02.038
166. Di Pierro F., Villanova N., Agostini F., Marzocchi R., Soverini V., Marchesini G., Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes, Metabolic Syndrome and Obesity 2012 5 213 217 10.2147/DMSO.S33718